News

Current guidelines suggest limiting diagnostic testing for chronic spontaneous urticaria when no clear cause is suspected, though biomarkers and biopsies are emerging as tools to predict treatment ...
Physicians should keep the possibility of comorbid atopic dermatitis in older patients top-of-mind: Following an analysis of the medical records of 837 patients with chronic urticaria ranging in ...
Patients with CSU have a higher burden than patients with CIndU, including on quality of life, economic effect, and knowledge about treatment.
Most people with eczema experience periods when their symptoms — dry, itchy skin and rashes — flare up, followed by periods of remission, when the symptoms improve or clear up. What triggers ...
Skin health experts have cautioned against the excessive use of bath sponges, warning that bathing with them more than two or three times a week could ...
However, the relationship between early-life antibiotic use and eczema was likely to be confounded by shared familial environment and genetic factors. 25 However, current data lacked the information ...
Urticaria is a heterogeneous group of diseases involving the onset of pruritic wheals, angio-oedema or both. 1–4 Chronic urticaria is diagnosed when recurrent crops of urticaria continue for more than ...
Nektar’s shares have surged more than twofold after a Phase IIb study of its atopic dermatitis (AD) therapy rezpegaldesleukin (rezpeg) successfully met its primary and key secondary endpoints. The ...
The placebo-controlled Phase 2b test evaluated three doses of the Nektar drug, rezpegaldesleukin (rezpeg for short), in 393 patients with moderate-to-severe atopic dermatitis, also called eczema.
Stress significantly impacts skin health, potentially triggering conditions like acne, eczema, and psoriasis. Stress hormones ...
The SPOTLIGHT study is a Phase 1b/2a open label clinical trial evaluating a single dose of subcutaneous briquilimab in adult participants with cold urticaria (ColdU) or symptomatic dermographism ...